References
- 1. McDonald LC, Gerding DN, Johnson S, et al. . Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018; 66: e1-48.10.1093/cid/cix1085
- 2. Lee YM, Huh KC, Yoon SM, et al. Incidence and Clinical Outcomes of Clostridium difficile Infection after Treatment with Tuberculosis Medication. Gut Liver. 2016;10(2):250-254. doi:10.5009/gnl1443510.5009/gnl14435
- 3. Obuch-Woszczatyński P, Dubiel G, Harmanus C, et al. Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland. Eur J Clin Microbiol Infect Dis. 2013;32(8):1027-1030. doi:10.1007/s10096-013-1845-510.1007/s10096-013-1845-5